ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0007193;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.117698628726131;28.36322711391944;5.334422371190153;9.492916862557204E-4;0.6478026081386739;[CHRM2, GABBR1, CHRM1, GPR37, HTR1E, NPY1R, GRIK3, FPR2, GNAI1, GNAI2, MARCO, GRM5, ADCY9, RGS1, HRH4, PSAP, FLNA, S1PR3, DRD4]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, ANPEP, CLEC5A, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, GYPA, DPP4, NCAM1, GPR15]
GO:0060441;epithelial tube branching involved in lung morphogenesis;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;53.5045405888233;7.004484905440688;0.0017907488225476112;0.7091290490632969;[HHEX, CTSZ, HOXA5]
GO:1904037;positive regulation of epithelial cell apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;105.42595785554589;6.375876246018314;0.0035285119322230004;0.701062607729944;[GSN, SORT1, FASLG, EIF2S1, THBS1, CD40LG, CCL2, PLCG1]
GO:0009313;oligosaccharide catabolic process;5.0;0.6763753087927167;0.6284286662572787;8.458452999841867;68.60352119966694;7.069023426578259;0.0022960981153922187;0.6517511986393402;[GM2A, SLC3A1]
GO:1903206;negative regulation of hydrogen peroxide-induced cell death;9.0;0.8436909121759173;0.8180860812682478;9.589303539338841;500.078557460717;6.8867018697843045;0.01673717927672765;0.7484268790654467;[GPR37, LRRK2, PSAP]
GO:0046697;decidualization;4.0;1.0;0.75;9.628524252492122;34.68251427445171;6.781341354126479;0.0011607925405295219;0.5967981122146513;[GHSR, PTGS2, MEN1, CTSB]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[FASLG, TNF, SORT1, TNFRSF10B]
GO:0006689;ganglioside catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;1346.4269631740738;7.9853141584524145;0.04506369875183998;0.8046099625986299;[GM2A]
GO:0060742;epithelial cell differentiation involved in prostate gland development;5.0;0.8653626801206646;0.7229223519212526;9.310070521373587;43.82069192109257;7.474488534686424;0.0014666391225366452;0.6724867031240476;[PSAP]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[LRRK2, CTSZ, RUVBL2, STMN1, AKT1, AES, SLPI, ADRB2, EPB41L5, CCL23, CAV1, EIF2S1, PPP1CA]
GO:0006004;fucose metabolic process;6.0;0.811012628672052;0.7286266269261705;9.310070521373587;34.676020684410545;7.004484905440688;0.0011605752059146955;0.6813299963962409;[FUCA1]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[CTSZ, FASLG, MYB, JUN, TGFB2, IL1B, UBE2M]
GO:0006027;glycosaminoglycan catabolic process;6.0;0.7866048967936545;0.7164227609869718;9.245532000236016;234.16675596998346;5.618190544320798;0.00783735058591714;0.610434838299289;[SDC2, GNS, PKHD1, TGFB1, FUCA1, OMD, DCN, OGN, SDC1, CSPG4]
GO:0006687;glycosphingolipid metabolic process;7.0;0.6763753087927167;0.6891070196535589;9.040737587590003;147.45961877692685;5.734022359845919;0.004935340735422783;0.64415753539903;[GAL3ST1, GM2A, PSAP, KIT]
GO:0002003;angiotensin maturation;8.0;1.0;0.875;9.628524252492122;184.72117518317427;7.379178354882098;0.00618245149511628;0.7523715242355574;[ENPEP, ACE, MME, CTSZ, CTSG]
GO:0051345;positive regulation of hydrolase activity;5.0;0.5651597194614189;0.5728208715916296;7.415551318187763;32.99397842971059;3.161008442547652;0.0011042787653896369;0.4518951306147327;[AKT1, MEF2C, AGTR1, NCKAP1L, PLCG1, LYN, JUN, EZH2, ARHGAP9, DENND1B, ITK, ARHGAP6, ARHGAP4, FCRL3, GMIP, SIRT1, CCL13, PTAFR, NTF3, CCL19, CCL18, CCL23, GSN, CCL20, NR1H2, CXCL13, TNF, CTGF, PYCARD, F2R, TPM1, MSH6, ACAP1, MSH2, S100A8, ADAP2, EVI5, TNFRSF10B, LRRK2, FASLG, GM2A, TAGAP, CR1, PPP1R12A, LCK, XCL1, NLRC4, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, P2RX1, SFRP2, PFN1, LLGL2, RACGAP1, NRP1, CTSH, CCR7, RHOG, AVPR1A, VAV1, KIT, PCNA, RANBP2, RANBP1, NLRP12, SIPA1, RGS1, ARHGDIA, ARHGDIB, PDGFRB, TSC2, ATP1B2, ATP1B1, PRTN3, PSMD14, C5AR1, ARHGAP15, RASGRP4, NLRP3, CAV2, CAV1, SELE, ARHGAP25, TBCK, ARHGAP30, HMGB2, TBC1D9, ARAP3, ARAP1, AXIN2, DNM2, IFNG, ALDH1A1, ASAP2, HSPD1, HSPE1, MAPK14, SSBP1]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, SERPINA1, PROS1, ITGB3, ITGA2B, F13A1, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, ANXA5, ACTN4, F5, PECAM1, TLN1, VCL, STXBP2, THBS1, PSAP, FLNA, LYN, TGFB2, TGFB1, EGF, LHFPL2, PPBP, CD9, PF4]
GO:0097067;cellular response to thyroid hormone stimulus;6.0;0.8933024483968273;0.7697715367885581;9.485423408851448;110.48347060425422;7.004484905440688;0.003697782332456301;0.6813299963962409;[GHSR, KIT, CTSH, GAS2L1, CTSS, CTSB]
GO:0051005;negative regulation of lipoprotein lipase activity;7.0;1.0;0.8509193652572005;9.628524252492122;65.18845533903233;8.16763571524637;0.0021817989343965133;0.7686126355688037;[SORT1]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, AKT1, GHSR, SIRT1, CEACAM1, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, SORBS1]
GO:0071310;cellular response to organic substance;4.0;0.44223782556504454;0.47111891278252227;5.954033535830285;41.65973036582596;2.624021992742989;0.0013943136840210083;0.3841926067383783;[CYFIP1, PID1, TFRC, SPINT2, PHB2, MYB, AKT1, PRKACB, MEF2C, ADCY9, SPINT1, PRKAR1B, PADI2, ABCB4, FPR2, GATA3, SLC30A10, ADAMTS12, IQGAP3, EPB41L5, KLRK1, PRKAR2B, PDGFD, PDGFC, ST3GAL6, PLCG1, LYN, ABCA1, JUN, JUP, CDC6, COL1A1, NOX4, EZH2, GABRB1, TIMP3, HLA-DPA1, HAVCR2, ANXA1, DUSP1, ARG1, FOS, SIRT1, PAX2, CCL13, PTAFR, PTGS2, CCL19, CCL18, IL12RB1, P2RY13, CCL23, GSN, CCL20, NR1H2, ZYX, PF4, TNC, CXCL13, TNF, SLC8A1, PYCARD, CDH1, RUVBL2, MEN1, TLE4, LHCGR, DGAT2, CD180, ADAM9, CD274, BLM, CALCRL, CORO1A, FOXO1, PSAP, IGFBP7, MAP2K6, OSBPL7, DEFA4, DEFA1, NFKB1, CXCL10, CXCL11, SLC26A3, MCM7, LRRK2, TREM2, PTPN22, ALAD, CHUK, TNFRSF1B, XCL1, MCM2, CX3CR1, LRP1, CEBPE, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, KLF1, RAD51, KLF5, IMPDH2, PTPN6, FCGR2B, AQP9, TCL1A, EDNRB, TNFSF11, PTGDR, RUNX2, POR, KCNQ1, BTK, SIK1, EPHA3, CFTR, STXBP2, EGR1, EGR2, EGR3, PPBP, ROBO2, NRP1, CTSS, CTSH, FFAR2, CTSG, CCR7, CD36, CCR5, CTSB, MAP4K1, MME, PDCD1LG2, AVPR1A, CEACAM1, IL1B, KIT, TLR6, TLR4, TLR2, DTYMK, PTGER2, CXCR4, GNAI1, PAK1, CD58, LILRB1, LILRB2, SORBS1, NLRP12, CD68, RAMP1, IL18R1, IL17A, CD86, CD80, PDGFRB, GHSR, KMO, KIF16B, COL4A1, CALCA, CSF2RB, ADRB2, STAP1, NLRP3, GAS2L1, TGFB1, CAV1, INHBA, BSPRY, NR4A2, NFKBIA, NR4A1, LIN28A, ALPL, CXCL6, CXCL9, HMGB2, TNFAIP3, CXCL1, CXCL3, CXCL2, CXCL5, GHR, TMEM100, GRM5, PDE4B, GLP2R, DNM2, CHI3L1, COLEC12, THBS1, MAPK14, TSHR, CD4, RBMX]
GO:0010757;negative regulation of plasminogen activation;10.0;1.0;0.9152410118609203;9.628524252492122;820.5340776865997;7.9853141584524145;0.027462537147443688;0.8236103492792612;[CTSZ, THBS1]
GO:0010977;negative regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;494.1264199049594;4.793467005972133;0.016537966589312465;0.6413787507847162;[NRP1, SEMA5B, LRRK2, CTSZ, ARHGAP4, ARHGDIA, TNR, DCC, PAQR3, RGMA, NLGN1, LRP1, LINGO1, PLK2, SEMA4B, PTK2, ITM2C]
GO:0032509;endosome transport via multivesicular body sorting pathway;6.0;0.8436909121759173;0.7449657686781032;9.446202695698167;62.963525230995856;6.599019797332524;0.002107332525987629;0.6605944919115335;[SORT1]
GO:0042340;keratan sulfate catabolic process;8.0;1.0;0.875;9.628524252492122;411.1022627208988;7.292166977892469;0.013759222765252392;0.747921758369865;[OGN, OMD, GNS]
GO:2000179;positive regulation of neural precursor cell proliferation;6.0;0.8259837884571596;0.7361122068187242;9.186691500213083;64.30534655244489;6.015873511986907;0.00215224207805574;0.6307723637598831;[LYN, CX3CR1, SMARCD3, EGF, CTSZ, LRP2, GNAI2, FLNA]
GO:0051603;proteolysis involved in cellular protein catabolic process;6.0;0.6519675769143192;0.6491041010473041;8.270400768338927;49.64990487012002;3.4509241545253704;0.001661737633989536;0.49960073433695684;[, ADAMTS12, HACE1, TGFB1I1, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, USP9Y, PSMC6, PSMC2, CUL5, WFS1, HM13, RNF24, SKP2, CTSZ, CTSS, CTSH, CTSB, RANBP2, RANBP1, PSMD14, TNFAIP3]
GO:0016139;glycoside catabolic process;6.0;0.7140352122741334;0.6801379187272112;8.712233520617966;75.12934532068766;7.474488534686424;0.0025145115758623713;0.7053660038532718;[FUCA1]
GO:1905572;ganglioside GM1 transport to membrane;8.0;1.0;0.875;9.628524252492122;123.75745464024328;9.777073627680469;0.00414205063233081;0.875;[PSAP]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, GATA3, TNF, FOXO1, TGFB1, JAG1, SORT1, SIRT1]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, ITGAM, FCAR, ALAD, FCGR3B, GM2A, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0008333;endosome to lysosome transport;6.0;0.8436909121759173;0.7449657686781032;9.36615998802463;62.67584315854233;5.769740442447999;0.0020977040659196657;0.618185107137305;[ADRB2, SORT1, VPS41]
GO:0046323;glucose import;10.0;0.8933024483968273;0.861892236059334;9.461470167828956;38.205824888540654;7.212124270218933;0.00127871457600939;0.7840693824379941;[SORT1]
GO:0060736;prostate gland growth;4.0;0.8653626801206646;0.6826813400603323;9.405380701177911;43.8113314783287;7.474488534686424;0.00146632583694119;0.6322456912631272;[PSAP]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, PHB2, PROK2, TNFSF11, EPHB1, MIF, EPHA3, FPR1, TGFA, FPR2, SLC30A10, IQGAP3, PDGFD, PDGFC, ELANE, CCR1, JUN, FZD5, MARCO, NOX4, CD24, EZH2, NRP1, CCR7, CD36, HAVCR2, MAP4K1, GPR37, SYK, FCRL3, DUSP6, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CCL13, CXCR4, GNAI2, PAK1, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL20, CARD9, CD40LG, PKN1, TNF, CTGF, PYCARD, PDGFRB, MAP2K2, F2R, ADAM9, C5AR1, TNFRSF11A, ADRB2, PSAP, DRD4, MAP2K6, TGFB2, TGFB1, CAV2, GH1, CSPG4, LRRK2, TREM2, PTPN22, GHR, CHI3L1, XCL1, PDE5A, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, EGF, TIE1, MAPK14, CD4, LTBR, TEK, FCGR2B]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[TFRC, KIAA1109, CUBN, SLC11A1, FPR2, IGHA1, ELANE, MSR1, MARCO, DENND1B, ASGR1, ASGR2, CD36, ANXA1, FCER1G, SYK, ANXA3, CEACAM1, RHOU, CD302, IGKC, CXCR1, CXCR2, SORT1, LILRB1, SIGLEC1, RAMP1, SCARB2, NCF4, HP, CXCL16, PYCARD, AP2M1, CD93, TSC2, PRTN3, CALCRL, PLD4, ADRB2, CORO1A, IGLV1-44, CD163, SYT2, CAV2, CAV1, LRP1B, MARCH3, IGKV3-20, LRP12, LRRK2, ITGB3, GHR, DNM2, PECAM1, COLEC12, NLGN1, LRP1, CEBPE, LRP2, DLL1, FCGR1B, ATP9A, NLGN4Y, CD6, CD9, FCGR2B]
GO:0006895;Golgi to endosome transport;7.0;1.0;0.8509193652572005;9.628524252492122;52.5351401021073;6.8867018697843045;0.0017583038606610233;0.7031056191423581;[SORT1, KIF16B]
GO:0038180;nerve growth factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;27.195621953761602;7.292166977892469;9.102129923216596E-4;0.7238411236270654;[SORT1, NTF3, CORO1A]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[SERPINA1, CTSZ, TGFA, F5]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, MEN1, MEF2C, COL4A1, ADAM9, HOXB5, GATA3, PSAP, ST14, JUN, TGFB1, JAG1, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CTSB, DSP, ANXA1, PAX2, ELF3, TAGLN, PCNA, E2F7, USH2A, GRHL2]
GO:0048011;neurotrophin TRK receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;58.19790639729547;6.781341354126479;0.0019478315524021762;0.7217981122146513;[SORT1]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[CALCA, SORT1, NPY1R, GPR84, SORCS3, PNOC, PROK2, GPR19]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[, PROS1, NRBP1, COPB2, TGFA, SPTA1, SERPINA1, CTSZ, SPTAN1, TMED6, F5, RAB33B, GOPC]
GO:0010506;regulation of autophagy;6.0;0.6260725219892441;0.6361565735847665;8.273978589686811;43.35793677134884;4.08334148887777;0.001451151124127319;0.5319425862261522;[AKT1, FZD5, PLK2, PTK2, SIRT1, RAB33B, TSC2, ADRB2, FOXO1, PSAP, OSBPL7, PLEKHF1, LRRK2, PTPN22, DCN, IFNG]
GO:0019377;glycolipid catabolic process;7.0;0.7980440201809971;0.7499413753476991;9.437469015729413;279.07397199981904;7.138016298065211;0.0093403546925652;0.7159578506919597;[GM2A, FUCA1]
GO:0014902;myotube differentiation;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;22.452520143917486;7.379178354882098;7.514656432606705E-4;0.7004918368257019;[MEF2C, SORT1, AVPR1A]
